http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Mechanism of Synergetic Growth of Flexibility and Strength of Biomimetic Nanocomposite Fibre
Xiangyu Duan,Pan Li,Jingyu Ouyang,Zichen Gao,Jiaxin Liu,Jie Wang,Zhigang Xia,Weilin Xu 한국섬유공학회 2022 Fibers and polymers Vol.23 No.3
Nanocomposites with carbon nanotubes (CNTs) can combine the stiffness and multi-functionality of carbonnanotubes with the advantages of high toughness and processability of polymers giving rise to properties different from thatof general composites. However, when the content of CNTs increases gradually, the flexibility of the composite fibre canreduce. In this paper, we propose a simple method of softening the composite fibre via dimensional helical deformation offibre inner macromolecule bundles to avoid the deterioration of fibre flexibility. The theoretical simulations were conductedto predict proper helical deformations of the single fibre to increase fibre softness, followed by practical softening of thepolyvinylidene difluoride (PVDF)/CNTs composite by tensional twisting of the single fibres. The fibres with and withouttensional twisting were tested by Fourier-transformed infrared spectroscopy, scanning electron microscopy, X-ray diffractionand mechanical drawing. Results showed the reinforcement of the PVDF/multi-walled CNTs composite fibres (tensilestrength enhanced from 4.71 to 5.19 cN/dtex) with an evident softness reduction (initial modulus increased from 16.8 to20.52 cN/dtex) as the CNTs content increased from 0 to 1.5 wt%. After the tensional twisting, the initial modulus of thecomposite fibre was reduced by 62.5 % while the fibre strength remained reinforced because biomimetic helix formationimproved the internal structure deformation ability of the fibre.
Prognostic Impact of Cyclin D1, Cyclin E and P53 on Gastroenteropancreatic Neuroendocrine Tumours
Liu, Shu-Zheng,Zhang, Fang,Chang, Yu-Xi,Ma, Jie,Li, Xu,Li, Xiao-Hong,Fan, Jin-Hu,Duan, Guang-Cai,Sun, Xi-Bin Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.1
Conventional classifications of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are rather unsatisfactory because of the variation in survival within each subgroup. Molecular markers are being found able to predict patient outcome in more and more tumours. The aim of this study was to characterize the expression of the proteins cyclin D1, cyclin E and P53 in GEP-NETs and assess any prognostic impact. Tumor specimens from 68 patients with a complete follow-up were studied immunohistochemically for cyclin D1, cyclin E and P53 expression. High cyclin D1 and cyclin E immunostaining (${\geq}$ 5% positive nuclei) was found in 48 (71%) and 24 (35%) cases, and high P53 staining (${\geq}$ 10% positive nuclei) in 33 (49%). High expression of P53 was more common in gastric neuroendocrine tumors and related to malignant behavior, being associate with a worse prognosis on univariate analysis (RR=1.9, 95%CI=1.1-3.2). High expression of cyclin E was significantly associated with shorter survival in the univariate analysis (RR=2.0, 95%CI=1.2-3.6) and multivariate analysis (RR=2.1, 95%CI=1.1-4.0). We found no significant correlation between the expression of cyclin D1 and any clinicopathological variables. Our study indicated a prognostic relevance for cyclin E and P53 immunoreactivity. Cyclin E may be an independent prognostic factor from the 2010 WHO Classification which should be evaluated in further studies.